ClinConnect ClinConnect Logo
Search / Trial NCT06448520

Reference Values for the Muscle Power Sprint Test

Launched by ERASMUS MEDICAL CENTER · Jun 4, 2024

Trial Information

Current as of May 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the Muscle Power Sprint Test (MPST) to develop updated reference values for children aged 5 to 12 years. In simple terms, the researchers want to find out what is considered "normal" performance for kids in this age group when they do short sprints. To do this, children will be asked to run six short sprints of 15 meters each, with a brief break in between.

To participate, children need to be between 5 and 12 years old and either attend a participating school or an after-school care program. However, kids with certain health issues, like serious heart or breathing problems, injuries that prevent them from exercising, or conditions that affect their movement, are not eligible to join. This study is currently looking for participants, and it’s a great opportunity to help create valuable information that can benefit kids' health and fitness in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 5-12 years
  • Attending primary education at one of the participating schools or attending participating after-school childcare centers.
  • Exclusion Criteria:
  • Contra-indication for maximal exercise due to cardiac or respiratory morbidities
  • Injuries limiting maximal exercise capacity
  • Known with motor function impairment which may hamper maximal exercise (e.g. neurologic comorbidities)

About Erasmus Medical Center

Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.

Locations

Rotterdam, South Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Marco Schnater, MD, PhD

Principal Investigator

Erasmus Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported